Cook Kevin A, White Andrew A
Division of Allergy and Immunology, Scripps Green Hospital, La Jolla, CA, USA.
Curr Allergy Asthma Rep. 2016 Feb;16(2):11. doi: 10.1007/s11882-015-0593-2.
Aspirin allergy in a patient with acute coronary syndrome represents one of the more urgent challenges an allergist may face. Adverse reactions to aspirin are reported in 1.5% of patients with coronary artery disease. A history of adverse reaction to aspirin often leads to unnecessary withholding of this medication or use of alternative antiplatelet therapy which may be inferior or more costly. Aspirin therapy has been shown to reduce morbidity and mortality in patients with coronary artery disease. Rapid aspirin challenge/desensitization in the aspirin allergic patient has been consistently shown to be both safe and successful in patients with acute coronary syndromes.
急性冠状动脉综合征患者的阿司匹林过敏是过敏症专科医生可能面临的较为紧迫的挑战之一。据报道,1.5%的冠心病患者会出现阿司匹林不良反应。阿司匹林不良反应史常常导致不必要地停用这种药物,或使用效果可能较差或成本更高的替代抗血小板疗法。阿司匹林治疗已被证明可降低冠心病患者的发病率和死亡率。对于阿司匹林过敏的患者,快速阿司匹林激发试验/脱敏治疗已被一致证明对急性冠状动脉综合征患者既安全又有效。